August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volume = 250 mL, Total fentaNYL 500 mcg/250
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls morphine in 0.9% sodium chloride, 125 mg/25 mL, (5 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services,
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride, Total Volume = 50 mL, Total fentaNYL 75 mcg/50 mL
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls PHENYLephrine in 0.9% sodium chloride, 1000 mcg/10 mL, (100 mcg/mL), 10 mL syringe, Rx only, Central Admixture Pharmacy
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls morphine in 0.9% sodium chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, I
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls morphine in 0.9% sodium chloride, 1 mg/1 mL, (1 mg/mL), 3 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc.
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 5000 mcg/250 mL, (20 mcg/mL), 250 mL Bag, Rx only, Central Admixture Pharmacy Services
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL syringe, Rx only, Central Admixture Pharmacy Services,
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 2500 mcg/250 mL, (10 mcg/mL), 250 mL bag, Rx only, Central Admixture Pharmacy Services
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Servic
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 1000 mcg/100 mL, (10 mcg/mL), 100 mL bag, Rx only, CAPS, Central Admixture Pharmacy Se
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Serv
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in Dextrose 5%, 0.5 mg/5 mL (0.1 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, S
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls succinylcholine, 200 mg/10 mL, (20 mg/mL), 10 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, C
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Serv
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 500 mcg/50 mL, (10 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Service
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 100 mcg/10 mL, (10 mcg/mL), 10 mL Syringe, Rx only, Central Admixture Pharmacy Service
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone added to 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 100 mL bag, Rx only, Central Admixture Pharmacy S
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 5000 mcg/100 mL, (50 mcg/mL), 100 mL Bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Ro
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 100 mL bag, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc.
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls vecuronium, 10 mg/10mL, (1 mg/mL), 10 mL syringe, Rx only, PARALYZING AGENT, CAPS, Inc., 7935 Dunbrook Road, Suite C, Sa
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Roa
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 100 mcg/2 mL, (50 mcg/mL), 3 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Roa
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 6 mg/30 mL, (0.2 mg/mL), 30 mL Syringe, Rx only, CAPS, Central Admixture Pharmacy
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 1250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc.,
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, 24 mEq K, Maintenance 8:1 non-enriched, Low Potassium, IV Bag, Total Volume = 300 mL, RX only, Ce
Hazard: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, 24 mEq K, Maintenance 8:1, Low Potassium, IV Bag, total volume = 500 mL, Rx only, Central Admixtu
Hazard: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.